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for resection of rectal cancer. Other fields of progress include sur-
gery for local recurrence, hepatic and pulmonary metastases as well 
as peritoneal carcinomatosis. The latter can now successfully be 
treated by cytoreduction and hyperthermic intraperitoneal chemo-
therapy in selected cases. While advanced tumor stages are treated 
more radically today, minimally invasive surgical techniques are 
also used more and more frequently. They are as reliable and good 
as open conventional surgical techniques; however, even today only 
a minority of cases is resected laparoscopically in Germany.
Local resections of low-risk tumors of the rectum can be suc-
cessfully performed by transanal endoscopic microsurgical tech-
niques without a compromise of oncological outcome. Several 
minimally invasive methods do exist, but apart from laparoscopy, 
none is widely used.
For stage II/III rectal cancer, neoadjuvant radiotherapy is supe-
rior to adjuvant treatment. While short-course radiation and long-
course chemoradiotherapy (LC-CRT) both reduce the rate of local 
recurrence, LC-CRT additionally aims to downsize the tumor. 
Clinical studies presently investigate the optimal choice, duration, 
and sequence of chemotherapy to be used in combination with 
radiation.
While surgical resection remains the gold standard for the treat-
ment of liver metastases, several options are available for treating 
non-resectable metastases. These include radiofrequency ablation, 
microwave ablation, transarterial chemoembolization, selective in-
ternal radiation therapy, and stereotactic body radiotherapy. Mul-
tidisciplinary tumor boards are an essential platform for proper 
discussion of complex cases in the light of multiple treatment op-
tions to allow individualized decision making. 
Patients with stage III and high-risk stage II colon cancers typi-
cally receive adjuvant chemotherapy to reduce the rate of recur-
rence and allow for improved survival. In stage IV disease, the im-
plementation of targeted therapy has substantially improved the 
New diagnostic and therapeutic options for colorectal cancer 
patients are associated with an increasing complexity of cancer 
care. Since colorectal cancer is one of the most frequent cancers in 
the Western world, evidence-based guidelines advocate multi-
modal treatment regimens as well as the need for interdisciplinary 
teams. The cornerstones of therapy are surgery, neoadjuvant 
radio(chemo)therapy (for patients with rectal cancer), and adju-
vant chemotherapy. Consequently, centralization of care, certifica-
tion of oncological centers with quality-assured tumor boards, and 
establishment of comprehensive cancer centers have led to an in-
creased quality of care as well as to an improved long-term survival 
throughout Germany. The articles of this special issue focus on dif-
ferent aspects of care for colorectal cancer and describe the stan-
dards as well as the latest developments.
Apart from age and hereditary forms, lifestyle factors such as 
low physical activity, excessive alcohol consumption, smoking, and 
nutrition are well-known risk factors for colorectal cancer. The lat-
est evidence demonstrates that physical activity may not only re-
duce the risk of colon cancer but may also be a valuable element of 
supportive care once a cancer has been diagnosed.
Screening programs are useful and, apart from colonoscopy, 
tests for occult fecal blood are established. New immunochemical 
tests have been developed and virtual colonoscopy and capsule en-
doscopy are promising, though not yet established alternatives to 
endoscopy. Proper staging of tumor disease is an important pre-
requisite of optimal subsequent therapy and includes computed 
tomography, magnetic resonance imaging, and endosonography.
Surgical resection clearly is an important requirement for long-
term survival and cure of colorectal cancer. Great improvements of 
surgical technique, training of surgeons, as well as centralization 
have increased the quality of resections and long-term survival. On-
cological lymph node dissection is required. Thus, total mesorectal 
excision and the Holms procedure are well-recognized standards 
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overall survival to more than 30 months in recent trials. Today, 
molecular characterization of the tumor including RAS, BRAF, and 
MSI is a first and important step in the development of a personal-
ized treatment approach. In the molecular subgroups, the selection 
of proper treatment sequences remains the focus of scientific dis-
cussion. New strategies involve the use of anti-PD1(PD-L1)-di-
rected immunotherapies. Despite these advances, life expectancy is 
still limited in metastatic disease. Therefore, new strategies based 
on molecular biomarkers are needed. Her2/neu and checkpoint in-
hibition might be useful in subgroups of patients.
Treatment of colorectal cancer is getting more and more com-
plex. Several medical disciplines are involved and the multimodal 
treatment approaches need to be discussed in interdisciplinary 
teams to design the best treatment for the individual patient. Ac-
cordingly, the review articles in this issue of Visceral Medicine 
present today’s standards as well as the latest improvements.
